Mohammed Vi University Hospital

This study looked at whether a daily dose of SGLT2 inhibitors (dapagliflozin or empagliflozin), drugs typically used for diabetes, could help people without diabetes who had a heart attack and a procedure to open blocked arteries. The goal was to see if the drug could lower the c…